Aspira Pathlab & Diagnostics Ltd — Insider Trading, 24-06-2026: Insider Trading / SAST

Aspira Pathlab & Diagnostics has closed its trading window for Designated Persons and their immediate relatives, effective July 1, 2026. This closure is ahead of announcing the financial results for the quarter ended June 30, 2026. The trading window will remain closed until 48 hours after these financial results are declared. The company will announce the date of the Board Meeting for these results in due course. This move helps maintain market integrity by preventing insider trading before key financial disclosures, ensuring all investors have access to information simultaneously.